Dan Zhu

Dan Zhu

Auto-generated profile, based on publicly available information

Dan Zhu

Department of Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2006 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DZDan Zhu
Dan Zhu
WXWen C. Xiong
Wen C. Xiong
LMLin Mei
Lin Mei
Agrin, a motoneuron-derived factor, and the muscle-specific receptor tyrosine kinase (MuSK) are essential for the acetylcholine receptor (AChR) clustering at the postjunctional membrane. However, the underlying signaling mechanisms remain poorly defined. We show that agrin stimulates a dynamic translocation of the AChR into lipid rafts-cholesterol and sphingolipid-rich microdomains in the plasma membrane. This follows MuSK partition into lipid rafts and requires its activation. Disruption of lipid rafts inhibits MuSK activation and downstream signaling and AChR clustering in response to agrin. Rapsyn, an intracellular protein necessary for AChR clustering, is located constitutively in lipid rafts, but its interaction with the AChR is inhibited when lipid rafts are perturbed. These results reveal that lipid rafts may regulate AChR clustering by facilitating the agrin/MuSK signaling and the interaction between the receptor and rapsyn, both necessary for AChR clustering and maintenance. These results provide insight into mechanisms of AChR cluster formation.

9 March 2015 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
DZDan Zhu
Dan Zhu
CLChenchen Li
Chenchen Li
ASAndrew M. Swanson
Andrew M. Swanson
RVRosa M. Villalba
Rosa M. Villalba
JGJidong Guo
Jidong Guo
EMErwin G Van Meir
Erwin G Van Meir
Synaptic plasticity is the ability of synapses to modulate the strength of neuronal connections; however, the molecular factors that regulate this feature are incompletely understood. Here, we demonstrated that mice lacking brain-specific angiogenesis inhibitor 1 (BAI1) have severe deficits in hippocampus-dependent spatial learning and memory that are accompanied by enhanced long-term potentiation (LTP), impaired long-term depression (LTD), and a thinning of the postsynaptic density (PSD) at hippocampal synapses. We showed that compared with WT animals, mice lacking Bai1 exhibit reduced protein levels of the canonical PSD component PSD-95 in the brain, which stems from protein destabilization. We determined that BAI1 prevents PSD-95 polyubiquitination and degradation through an interaction with murine double minute 2 (MDM2), the E3 ubiquitin ligase that regulates PSD-95 stability. Restoration of PSD-95 expression in hippocampal neurons in BAI1-deficient mice by viral gene therapy was sufficient to compensate for Bai1 loss and rescued deficits in synaptic plasticity. Together, our results reveal that interaction of BAI1 with MDM2 in the brain modulates PSD-95 levels and thereby regulates synaptic plasticity. Moreover, these results suggest that targeting this pathway has therapeutic potential for a variety of neurological disorders.

1 June 2018 in Cancer Cell
Verified
Journal Article
Closed access
DZDan Zhu
Dan Zhu
SOSatoru Osuka
Satoru Osuka
ZZZhaobin Zhang
Zhaobin Zhang
ZRZachery R. Reichert
Zachery R. Reichert
LYLiquan Yang
Liquan Yang
EMErwin G Van Meir
Erwin G Van Meir

30 August 2011 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DZDan Zhu
Dan Zhu
SHStephen B. Hunter
Stephen B. Hunter
PVPaula M. Vertino
Paula M. Vertino
EMErwin G Van Meir
Erwin G Van Meir
Brain angiogenesis inhibitor 1 (BAI1) is a putative G protein–coupled receptor with potent antiangiogenic and antitumorigenic properties that is mutated in certain cancers. BAI1 is expressed in normal human brain, but it is frequently silenced in glioblastoma multiforme. In this study, we show that this silencing event is regulated by overexpression of methyl-CpG–binding domain protein 2 (MBD2), a key mediator of epigenetic gene regulation, which binds to the hypermethylated BAI1 gene promoter. In glioma cells, treatment with the DNA demethylating agent 5-aza-2′-deoxycytidine (5-Aza-dC) was sufficient to reactivate BAI1 expression. Chromatin immunoprecipitation showed that MBD2 was enriched at the promoter of silenced BAI1 in glioma cells and that MBD2 binding was released by 5-Aza-dC treatment. RNA interference–mediated knockdown of MBD2 expression led to reactivation of BAI1 gene expression and restoration of BAI1 functional activity, as indicated by increased antiangiogenic activity in vitro and in vivo. Taken together, our results suggest that MBD2 overexpression during gliomagenesis may drive tumor growth by suppressing the antiangiogenic activity of a key tumor suppressor. These findings have therapeutic implications because inhibiting MBD2 could offer a strategy to reactivate BAI1 and suppress glioma pathobiology. Cancer Res; 71(17); 5859–70. ©2011 AACR.

11 November 2016
Verified
Book Chapter
Closed access
PDF file
GAGabriela Aust
Gabriela Aust
DZDan Zhu
Dan Zhu
EMErwin G Van Meir
Erwin G Van Meir
LXLei Xu
Lei Xu

13 February 2008 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DZDan Zhu
Dan Zhu
ZYZhihua Yang
Zhihua Yang
ZLZhenge Luo
Zhenge Luo
SLShiwen Luo
Shiwen Luo
WXWen C. Xiong
Wen C. Xiong
LMLin Mei
Lin Mei
Agrin, a factor used by motoneurons to direct acetylcholine receptor (AChR) clustering at the neuromuscular junction, initiates signal transduction by activating the muscle-specific receptor tyrosine kinase (MuSK). However, the underlying mechanisms remain poorly defined. Here, we demonstrated that MuSK became rapidly internalized in response to agrin, which appeared to be required for induced AChR clustering. Moreover, we provided evidence for a role ofN-ethylmaleimide sensitive factor (NSF) in regulating MuSK endocytosis and subsequent signaling in response to agrin stimulation. NSF interacts directly with MuSK with nanomolar affinity, and treatment of muscle cells with the NSF inhibitorN-ethylmaleimide, mutation of NSF, or suppression of NSF expression all inhibited agrin-induced AChR clustering. Furthermore, suppression of NSF expression and NSF mutation attenuate MuSK downstream signaling. Our study reveals a potentially novel mechanism that regulates agrin/MuSK signaling cascade.